Skip to main content
Premium Trial:

Request an Annual Quote

PhenomeX Beacon Select Optofluidic System

PhenomeX has launched the Beacon Select optofluidic system with Opto B Discovery workflows form antibody discovery. These products are suitable for small- to mid-sized biopharma companies and CDMOs/CROs, and enable researchers to conduct antibody screening to find lead candidates, PhenomeX said. This is in contrast to the company's four-chip Bacon system, which is optimized for higher-throughput screening at large biopharma companies and more established CDMOs/CROs, the company said. Beacon Select enables rapid function-first selection of single B cells with the best characteristics for any antibody application, including therapeutics, diagnostics, and reagents. In addition, the Opto B Discovery workflows are highly customizable to enable researchers to assess antigen and epitope specificity, species or variant cross-reactivity, and functional properties, all in a single-day workflow, the company said.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.